articleNew England Journal of MedicineJun 2, 2004BRONZE OA

Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer

Sorbonne Université · Hôpital Tenon · +10 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

The standard adjuvant treatment of colon cancer is fluorouracil plus leucovorin (FL). Oxaliplatin improves the efficacy of this combination in patients with metastatic colorectal cancer. We evaluated the efficacy of treatment with FL plus oxaliplatin in the postoperative adjuvant setting.

Methods

We randomly assigned 2246 patients who had undergone curative resection for stage II or III colon cancer to receive FL alone or with oxaliplatin for six months. The primary end point was disease-free survival.

Citation impact

3,646
total citations
FWCI
81.39
Percentile
100%
References
27
Citations per year

Authors

12

Topics & keywords

Keywords
  • Medicine
  • Oxaliplatin
  • Internal medicine
  • Hazard ratio
  • Colorectal cancer
  • Gastroenterology
  • Fluorouracil
  • Surgery
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding